Abstract
Objective
Kaliotoxin2 (KTX2) is a highly selective blocker of voltage-dependent potassium channels Kv1.3 containing 37 amino acid residues. It is purified from Androctonus australis scorpion venom. The binding of KTX2 to its targets is able to alter the neuronal excitability leading to neurological disorders, accompanied by an inflammatory response. In brain, activation of insulin receptor signaling pathway by insulin induces current suppression and concomitant tyrosine phosphorylation of Kv1.3 channel. The aim of this study is to evaluate the effect of insulin injected by i.c.v. route on the neuro-pathophysiological and systemic disorders induced by KTX2.
Materials and methods
Tissue damage, inflammatory response and oxidative stress biomarkers were assessed in NMRI mice at 24 h after co-injection of KTX2 and insulin by intracerebroventricular route.
Results
Obtained results revealed that the central administration of insulin prevents cerebral cortex injury, brain edema and blood–brain barrier alteration induced by KTX2, these are accompanied by significant decrease of systemic disorders including serum cytokines, inflammatory and oxidative stress markers and tissue damage.
Conclusion
These results indicate that insulin is able to reduce neuro-immunological effects and systemic disorders induced by KTX2. The neuroprotective effect of insulin may be due to its crucial role in the regulation of inflammation response and its properties to modulate the activity of Kv1.3 channels in brain.
Similar content being viewed by others
References
Rodriguez de la Vega RC, Possani LD. Current views on scorpion toxins specific for K+-channels. Toxicon. 2004;43(8):865–75. https://doi.org/10.1016/j.toxicon.2004.03.022.
Tytgat J, Chandy KG, Garcia ML, Gutman GA, Martin-Eauclaire MF, van der Walt JJ, et al. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol. Sci. 1999;20(11):444–7.
Tan PT, Veeramani A, Srinivasan KN, Ranganathan S, Brusic V. SCORPION2: a database for structure-function analysis of scorpion toxins. Toxicon. 2006;47(3):356–63. https://doi.org/10.1016/j.toxicon.2005.12.001.
Quintero-Hernandez V, Jimenez-Vargas JM, Gurrola GB, Valdivia HH, Possani LD. Scorpion venom components that affect ion-channels function. Toxicon. 2013;76:328–42. https://doi.org/10.1016/j.toxicon.2013.07.012.
Ortiz E, Gurrola GB, Schwartz EF, Possani LD. Scorpion venom components as potential candidates for drug development. Toxicon. 2015;93C:125–35. https://doi.org/10.1016/j.toxicon.2014.11.233.
Laraba-Djebari F, Legros C, Crest M, Ceard B, Romi R, Mansuelle P, et al. The kaliotoxin family enlarged. Purification, characterization, and precursor nucleotide sequence of KTX2 from Androctonus australis venom. J Biol Chem. 1994;269(52):32835–43.
Zachariae U, Schneider R, Velisetty P, Lange A, Seeliger D, Wacker SJ, et al. The molecular mechanism of toxin-induced conformational changes in a potassium channel: relation to C-type inactivation. Structure. 2008;16(5):747–54. https://doi.org/10.1016/j.str.2008.01.018.
Ladjel-Mendil A, Martin-Eauclaire MF, Laraba-Djebari F. Neuropathophysiological effect and immuno-inflammatory response induced by kaliotoxin of androctonus scorpion venom. Neuroimmunomodulation. 2013;20(2):99–106. https://doi.org/10.1159/000345706.
Taibi-Djennah Z, Matin-Eauclaire MF, Laraba-Djebari F. Systemic responses following brain injuries and inflammatory process activation induced by a neurotoxin of Androctonus scorpion venom. Neuroimmunomodulation. 2015. https://doi.org/10.1159/000371493.
Sifi N, Martin-Eauclaire MF, Laraba-Djebari F. K(+) channel blocker-induced neuroinflammatory response and neurological disorders: immunomodulatory effects of astaxanthin. Inflamm. Res. 2016;65(8):623–34. https://doi.org/10.1007/s00011-016-0945-y.
Bessone R, Martin-Eauclaire MF, Crest M, Mourre C. Heterogeneous competition of Kv1 channel toxins with kaliotoxin for binding in rat brain: autoradiographic analysis. Neurochem. Int. 2004;45(7):1039–47. https://doi.org/10.1016/j.neuint.2004.05.006.
Mourre C, Chernova MN, Martin-Eauclaire MF, Bessone R, Jacquet G, Gola M, et al. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits. J. Pharmacol. Exp. Ther. 1999;291(3):943–52.
Ladjel-Mendil A, Martin-Eauclaire MF, Laraba-Djebari F. Neuro-modulation of immuno-endocrine response induced by kaliotoxin of Androctonus scorpion venom. J. Biochem. Mol. Toxicol. 2016;30(12):580–7. https://doi.org/10.1002/jbt.21824.
Lu J, Goh SJ, Tng PY, Deng YY, Ling EA, Moochhala S. Systemic inflammatory response following acute traumatic brain injury. Front Biosci (Landmark Ed). 2009;14:3795–813.
Jacome T, Tatum D. Systemic inflammatory response syndrome (SIRS) score independently predicts poor outcome in isolated traumatic brain injury. Neurocrit. Care. 2018;28(1):110–6. https://doi.org/10.1007/s12028-017-0410-y.
Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 1978;272(5656):827–9.
Fadool DA, Tucker K, Phillips JJ, Simmen JA. Brain insulin receptor causes activity-dependent current suppression in the olfactory bulb through multiple phosphorylation of Kv1.3. J. Neurophysiol. 2000;83(4):2332–48.
Werner H, LeRoith D. Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects. Eur. Neuropsychopharmacol. 2014;24(12):1947–53. https://doi.org/10.1016/j.euroneuro.2014.01.020.
Franklin JL, Bennett WL, Messina JL. Insulin attenuates TNFα-induced hemopexin mRNA: an anti-inflammatory action of insulin in rat H4IIE hepatoma cells. Biochem. Biophys. Rep. 2017;9:211–216
Andreelli F, Jacquier D, Keufer F. Propriétés anti-inflammatoires de l’insuline chez les patients en réanimation. Réanimation. 2006;15(6):467–73.
Devos P. Effets propres de l’insuline par rapport au contrôle glycémique. Réanimation. 2008;17:8–11.
Bougle A, Annane D. Effect of insulin: from the cell to the total body. Ann. Fr. Anesth. Reanim. 2009;28(5):e193-9. https://doi.org/10.1016/j.annfar.2009.02.029.
Deng HP, Chai JK. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis. Int. Immunopharmacol. 2009;9(11):1251–9. https://doi.org/10.1016/j.intimp.2009.07.009.
Rosas-Hernandez H, Ramirez M, Ramirez-Lee MA, Ali SF, Gonzalez C. Inhibition of prolactin with bromocriptine for 28 days increases blood–brain barrier permeability in the rat. Neuroscience. 2015;301:61–70. https://doi.org/10.1016/j.neuroscience.2015.05.066.
Tao X, Chen X, Hao S, Hou Z, Lu T, Sun M, et al. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood–brain barrier after traumatic brain injury in mice. Neuroscience. 2015;291:26–36. https://doi.org/10.1016/j.neuroscience.2015.01.070.
Matos IM, Souza DG, Seabra DG, Freire-Maia L, Teixeira MM. Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats. Eur. J. Pharmacol. 1999;376(3):293–300.
Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al. Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer. 2006;119(6):1403–11. https://doi.org/10.1002/ijc.21989.
Okada N, Ishida H, Murata N, Hashimoto D, Seyama Y, Kubota S. Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer. Biochem. Biophys. Res. Commun. 2001;288(1):212–6. https://doi.org/10.1006/bbrc.2001.5741.
Coelho FM, Pessini AC, Coelho AM, Pinho VS, Souza DG, Arantes EC, et al. Platelet activating factor receptors drive CXC chemokine production, neutrophil influx and edema formation in the lungs of mice injected with Tityus serrulatus venom. Toxicon. 2007;50(3):420–7. https://doi.org/10.1016/j.toxicon.2007.04.009.
Van Oosterhout AJ, van Ark I, Hofman G, Van Der Linde HJ, Fattah D, Nijkamp FP. Role of interleukin-5 and substance P in development of airway hyperreactivity to histamine in guinea-pigs. Eur. Respir. J. 1996;9(3):493–9.
Sun XC, Li WB, Li SQ, Li QJ, Chen XL, Ai J. Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord. Acta Physiol. Sin. 2003;55(6):677–83.
Moreno I, Pichardo S, Jos A, Gomez-Amores L, Mate A, Vazquez CM, et al. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. Toxicon. 2005;45(4):395–402. https://doi.org/10.1016/j.toxicon.2004.11.001.
Sampaio SC, Sousa-e-Silva MC, Borelli P, Curi R, Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J. Leukoc. Biol. 2001;70(4):551–8.
Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6.
Ellman GL. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959;82(1):70–7.
Dardiotis E, Karanikas V, Paterakis K, Fountas K, Hadjigeorgiou GM. Traumatic brain injury and inflammation: emerging role of innate and adaptive immunity. In: Agrawal A, editor. Brain injury-pathogenesis, monitoring, recovery and management. Rijeka: InTech; 2012. p. 23–38.
Adi-Bessalem S, Hammoudi-Triki D, Laraba-Djebari F. Scorpion venom interactions with the immune system. In: Gopalakrishnakone P, editor. Toxinology: scorpion venoms. Dordrecht: Springer; 2013. p. 1–18. https://doi.org/10.1007/978-94-007-6647-1_3-1.
Jin W, Dong C. IL-17 cytokines in immunity and inflammation. Emerg. Microb. Infect. 2013;2(9):e60. https://doi.org/10.1038/emi.2013.58.
Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nat. Med. 2007;13(10):1173–5. https://doi.org/10.1038/nm1651.
de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. The blood–brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 1997;49(2):143–55.
Laraba-Djebari F, Adi-Bessalem S, Hammoudi-Triki D. Scorpion venoms: pathogenesis and biotherapies. In: Gopalakrishnakone P, editor. Toxinology: scorpion venoms. Dordrecht: Springer; 2013. p. 1–21. https://doi.org/10.1007/978-94-007-6647-1_2-1.
Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat. Inflamm. 2013;2013:928315. https://doi.org/10.1155/2013/928315.
Kossakowska AE, Edwards DR, Prusinkiewicz C, Zhang MC, Guo D, Urbanski SJ, et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin’s lymphomas. Blood. 1999;94(6):2080–9.
Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 2004;239(4):553–60.
Raouraoua-Boukari R, Sami-Merah S, Hammoudi-Triki D, Martin-Eauclaire MF, Laraba-Djebari F. Immunomodulation of the inflammatory response induced by Androctonus australis hector neurotoxins: biomarker interactions. Neuroimmunomodulation. 2012;19(2):103–10. https://doi.org/10.1159/000330241.
Griffin GK, Newton G, Tarrio ML, Bu DX, Maganto-Garcia E, Azcutia V, et al. IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol. 2012;188(12):6287–99. https://doi.org/10.4049/jimmunol.1200385.
Koffler M, Raskin P, Womble D, Helderman JH. Immunobiological consequence of regulation of insulin receptor on alloactivated lymphocytes in normal and obese subjects. Diabetes. 1991;40(3):364–70.
Viardot A, Grey ST, Mackay F, Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology. 2007;148(1):346–53. https://doi.org/10.1210/en.2006-0686.
Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metab. 2001;86(7):3257–65. https://doi.org/10.1210/jcem.86.7.7623.
Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J. Clin. Investig. 2005;115(8):2277–86. https://doi.org/10.1172/JCI25385.
Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann. Surg. 2004;240(2):340–9.
Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J. Hepatol. 2005;42(6):870–9. https://doi.org/10.1016/j.jhep.2004.12.036.
Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, et al. Immunologic privilege in the central nervous system and the blood–brain barrier. J. Cereb. Blood Flow Metab. 2013;33(1):13–21. https://doi.org/10.1038/jcbfm.2012.153.
Petricevich VL. Scorpion venom and the inflammatory response. Mediat. Inflamm. 2010;2010:903295. https://doi.org/10.1155/2010/903295.
Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 2006;26(2):149–88.
Imhof BA, Engelhardt B, Vadas M. Novel mechanisms of the transendothelial migration of leukocytes. Trends Immunol. 2001;22(8):411–4.
Man S, Ubogu EE, Ransohoff RM. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 2007;17(2):243–50. https://doi.org/10.1111/j.1750-3639.2007.00067.x.
Nguyen HX, O’Barr TJ, Anderson AJ. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J. Neurochem. 2007;102(3):900–12. https://doi.org/10.1111/j.1471-4159.2007.04643.x.
Li H, Liang J, Castrillon DH, DePinho RA, Olson EN, Liu ZP. FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 2007;27(7):2676–86. https://doi.org/10.1128/MCB.01748-06.
Kothari P, Pestana R, Mesraoua R, Elchaki R, Khan KM, Dannenberg AJ, et al. IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages. J Immunol. 2014;192(1):349–57. https://doi.org/10.4049/jimmunol.1301906.
Moretti R, Pansiot J, Bettati D, Strazielle N, Ghersi-Egea JF, Damante G, et al. Blood–brain barrier dysfunction in disorders of the developing brain. Front. Neurosci. 2015;9:40. https://doi.org/10.3389/fnins.2015.00040.
Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, et al. TGF-beta1 prevents blood–brain barrier damage and hemorrhagic transformation after thrombolysis in rats. Exp. Neurol. 2015;266:120–6. https://doi.org/10.1016/j.expneurol.2015.02.013.
Kanashiro A, Talbot J, Peres RS, Pinto LG, Bassi GS, Cunha TM, et al. Neutrophil recruitment and articular hyperalgesia in antigen-induced arthritis are modulated by the cholinergic anti-inflammatory pathway. Basic Clin. Pharmacol. Toxicol. 2016;119(5):453–7. https://doi.org/10.1111/bcpt.12611.
Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853–9. https://doi.org/10.1038/nature01321.
Chavan SS, Pavlov VA, Tracey KJ. Mechanisms and therapeutic relevance of neuro-immune communication. Immunity. 2017;46(6):927–42. https://doi.org/10.1016/j.immuni.2017.06.008.
Dianzani C, Collino M, Lombardi G, Garbarino G, Fantozzi R. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br. J. Pharmacol. 2003;139(6):1103–10. https://doi.org/10.1038/sj.bjp.0705344.
Khorchid A, Fragoso G, Shore G, Almazan G. Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3. Glia. 2002;40(3):283–99. https://doi.org/10.1002/glia.10123.
Dousset E, Carrega L, Steinberg JG, Clot-Faybesse O, Jouirou B, Sauze N, et al. Evidence that free radical generation occurs during scorpion envenomation. Comp. Biochem. Physiol. Toxicol. Pharmacol. CBP. 2005;140(2):221–6. https://doi.org/10.1016/j.cca.2005.02.003.
Fatani AJ, Furman BL, Zeitlin IJ. The involvement of plasma kinins in the cardiovascular effects of Leiurus quinquestriatus scorpion venom in anaesthetised rabbits. Toxicon. 1998;36(3):523–36.
Fukuhara YD, Dellalibera-Joviliano R, Cunha FQ, Reis ML, Donadi EA. The kinin system in the envenomation caused by the Tityus serrulatus scorpion sting. Toxicol. Appl. Pharmacol. 2004;196(3):390–5. https://doi.org/10.1016/j.taap.2003.12.026.
Mielke JG, Taghibiglou C, Wang YT. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience. 2006;143(1):165–73. https://doi.org/10.1016/j.neuroscience.2006.07.055.
Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front. Endocrinol. 2014;5:161. https://doi.org/10.3389/fendo.2014.00161.
Mamik MK, Asahchop EL, Chan WF, Zhu Y, Branton WG, McKenzie BA, et al. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV/AIDS neurodegeneration. J. Neurosci. 2016;36(41):10683–95. https://doi.org/10.1523/JNEUROSCI.1287-16.2016.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors confirm that there is no conflict of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Additional information
Responsible Editor: Thiago Mattar Cunha.
Rights and permissions
About this article
Cite this article
Taibi-Djennah, Z., Martin-Eauclaire, MF. & Laraba-Djebari, F. Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker. Inflamm. Res. 67, 863–877 (2018). https://doi.org/10.1007/s00011-018-1177-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-018-1177-0